Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
December 22, 2021updated 07 Jan 2022 8:52am

Coronavirus company news summary – Thermo Fisher updates Covid-19 mutation panel – US to offer Covid-19 test kits to fight Omicron

Thermo Fisher Scientific has revised its Applied Biosystems TaqMan SARS-CoV-2 Mutation Panel to facilitate direct identification of the Omicron variant of the virus. Made with an adaptable menu of real-polymerase chain reaction (PCR) genotyping assays, the panel can precisely detect all known Covid-19 variants in nearly over an hour. The panel works with real-time PCR devices that are currently utilised in laboratories across the globe. Labs may make their own unique, highly scalable panel by selecting from a menu of more than 50 known mutations of the virus. Furthermore, it can process up to several specimens to check for various mutations at the same time.

US President Joe Biden has announced the supply of 200 to 500 million free rapid Covid-19 test kits in the market under the Defense Production Act. In an interview with MSNBC, Chief Medical Advisor to the President Dr Anthony Fauci said that the officials were deliberating a reduced recommended quarantine duration for healthcare personnel, Reuters reported. Biden is anticipated to make an announcement on key changes in the Covid-19 winter plan soon.

Cue Health has collaborated with Air Canada to offer its molecular Covid-19 self-test to US-based passengers. These tests, which could be ordered three, six, or ten at a time, coupled with the reusable and portable Cue Cartridge Reader, are now available to Air Canada’s US-based clients. Meeting the travel testing needs of Canada, the nucleic acid amplification test delivers results in nearly 20 minutes. The testing services of Cue are anticipated to be roll-out for Canada-based users earlier next year.

Related Companies

Content from our partners
Precision wire: The future of bespoke medical treatment
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
“This technique means everything to us”: How CGM devices empower users 
Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU